Kathleen Liddell

University of Cambridge - Faculty of Law

10 West Road

Cambridge, CB3 9DZ

United Kingdom

SCHOLARLY PAPERS

17

DOWNLOADS
Rank 35,012

SSRN RANKINGS

Top 35,012

in Total Papers Downloads

1,252

CITATIONS
Rank 47,334

SSRN RANKINGS

Top 47,334

in Total Papers Citations

9

Scholarly Papers (17)

1.

Immorality and Patents: The Exclusion of Inventions Contrary to Ordre Public and Morality

In A Lever (ed), New Frontiers in the Philosophy of Intellectual Property (Cambridge CUP 2012), University of Cambridge Faculty of Law Research Paper No. 55/2016
Number of pages: 27 Posted: 08 Nov 2016
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 277 (109,107)
Citation 1

Abstract:

Loading...

Patents, Immorality, Ethics, EPC Article 53(a), EU Directive on Biotechnological Inventions, Exclusion For "Invention the Commercial Exploitation of Which Is Contrary to Morality or Order Public", Oncomouse, Embryo Stem Cell Patent

2.

Fair and Equitable Treatment and Judicial Patent Decisions

University of Cambridge Faculty of Law Research Paper No. 4/2016
Number of pages: 40 Posted: 26 Jan 2016
Kathleen Liddell and Michael Waibel
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 228 (133,142)
Citation 2

Abstract:

Loading...

intellectual property rights, patents, patent offices, patent invalidation, fair and equitable treatment, state responsibility for judicial conduct, deference to judicial conduct, Eli Lilly v. Canada

3.

Informed Consent for Research Using Biospecimens, Genetic Information and Other Personal Data

University of Cambridge Faculty of Law Research Paper No. 27/2017
Number of pages: 21 Posted: 15 Jun 2017 Last Revised: 03 Aug 2017
Kathleen Liddell and Jeffrey M. Skopek
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 180 (166,093)

Abstract:

Loading...

Informed consent, Biospecimens and personal data, Genetics research, Anonymization, Anonymisation, Return of research results, Return of incidental findings, Community consent, Property rights

4.

Open Innovation with Large Bioresources: Goals, Challenges and Proposals

University of Cambridge Faculty of Law Research Paper No. 6/2017
Number of pages: 35 Posted: 23 Dec 2016 Last Revised: 19 Jan 2017
Johnathon Liddicoat and Kathleen Liddell
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 114 (240,447)

Abstract:

Loading...

intellectual property, patents, bioresources, biobanks, synthetic biology, synbio, genomics, genomic medicine, IP policy, access policy, openness, open innovation, open science, open source

5.

Precision Medicine: Legal and Ethical Challenges

University of Cambridge Faculty of Law Research Paper No. 64/2017
Number of pages: 18 Posted: 16 Nov 2017 Last Revised: 06 Dec 2017
Johnathon Liddicoat, Jeffrey M. Skopek and Kathleen Liddell
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 103 (258,254)

Abstract:

Loading...

Precision Medicine, Law, Patent Law, Regulation, Genomics, Biobanks, Tort Law, Liability, Health Systems, Ethics, Challenges, Implantation, Clinical Treatment, Foundation Research, Translational Medicine, Conference Report

6.

Should We Change EU Law to Disallow DNA Patents?

Number of pages: 10 Posted: 28 Jan 2018
Kathleen Liddell and Johnathon Liddicoat
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 71 (324,738)
Citation 1

Abstract:

Loading...

Intellectual Property, Patent Law, DNA Patents, Gene Patents, Patent Eligibility, Patentable Subject Matter, EU Biotechnology Directive, AMP v Myriad

7.

Myriad's Impact on Gene Patents

Nature Biotechnology, Vol. 34, No. 11, p. 1119-1123, Nov. 2016, University of Cambridge Faculty of Law Research Paper No. 58/2017
Number of pages: 8 Posted: 04 Aug 2017 Last Revised: 25 Jun 2019
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 64 (343,229)
Citation 1

Abstract:

Loading...

Patents, BRCA, Myriad, Gene Patents, Patent Publications, Empirical Analysis

Pre-Mortem Interventions in Donation after Circulatory Death: A Proposal for Action

University of Cambridge Faculty of Law Research Paper No. 58/2016
Number of pages: 5 Posted: 30 Nov 2016
University of Cambridge - Faculty of Law, University of Cambridge - Department of Surgery, Faculty of Law and Corpus Christi College, University of Oxford, 39 Essex Chambers, University of Cambridge - Department of Surgery and University of Cambridge - Department of Surgey
Downloads 51 (389,053)

Abstract:

Loading...

Medical Ethics, Organ Donation, Donation after Circulatory Death, DCD, Medico-Legal, Organ Transplantation, Organ Transplants, Clinical Guidelines, Organ Transplantation Law, Mental Capacity, Best Interests, Research Ethics

Pre-Mortem Interventions in Donation after Circulatory Death: A Proposal for Action

Number of pages: 4 Posted: 22 Jan 2018
University of Cambridge - Faculty of Law, University of Cambridge - Department of Surgery, Faculty of Law and Corpus Christi College, University of Oxford, Essex Court Chambers, University of Cambridge - Department of Surgery and University of Cambridge - Department of Surgey
Downloads 9 (609,880)

Abstract:

Loading...

organ transplantation law, DCD, donation after cardiac death, pre-mortem interventions, heparin

9.

Realising Genomic Medicine: Intellectual Property Issues

Centre for Law Medicine and Life Sciences & Centre for Science and Policy Workshop Report, May 2015
Number of pages: 14 Posted: 23 Jan 2018
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 39 (425,830)
Citation 1

Abstract:

Loading...

Human Genome, Intellectual Property, Patent Law, Patents, DNA, Gene Patents, Biobanks, Genomics, Precision Medicine, Personalised Medicine, Biobanks, Bioresources, AMP v Myriad, Mayo v Prometheus

10.

The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline

Vanderbilt Journal of Entertainment & Technology Law, Forthcoming
Number of pages: 34 Posted: 29 May 2019
Johnathon Liddicoat, Kathleen Liddell and Mateo Aboy
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and LML, University of Cambridge
Downloads 28 (474,379)

Abstract:

Loading...

patent, patentable subject matter, patent eligibility, 35 USC 101, US, Europe, interviews, empirical, comparative

11.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 28 (474,379)
Citation 1

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

12.

Regulation of Sub-Optimal Organ Transplantation: A Primer

Number of pages: 8 Posted: 22 Jan 2018
Kathleen Liddell, Matthew Dyson and Kourosh Saeb-Parsy
University of Cambridge - Faculty of Law, Faculty of Law and Corpus Christi College, University of Oxford and University of Cambridge - Department of Surgey
Downloads 25 (490,292)

Abstract:

Loading...

organ transplantation, organ recipients, liability, sub-optimal organs, marginal organs, medical law, tort law, product liability

13.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 07 Aug 2019
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 16 (541,988)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

14.

Human Bodies: Regulatory Frameworks for Donations of Human Material for the Purposes of Medicine and Research

Liddell, Kathleen, Human Bodies: Regulatory Frameworks for Donations of Human Material for the Purposes of Medicine and Research (April 01, 2011).
Number of pages: 42 Posted: 23 Jan 2018
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 14 (553,952)

Abstract:

Loading...

medical law, bioethics, human body, research, human tissue, donation, legal, comparative medical law

15.

Continental Drift? Do European Clinical Genetic Testing Laboratories Have a Patent Problem?

European Journal of Human Genetics, 2019
Number of pages: 11 Posted: 01 Apr 2019
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, Unversity of Cambidge, King’s College London, Dept of Social Science, Health & Medicine, LML, University of Cambridge, University of Tasmania, European Molecular Genetics Quality Network and University of Sussex
Downloads 5 (610,781)

Abstract:

Loading...

patents, genetic tests, Europe, patent law

16.

IP Policies for Large Bioresources: The Fiction, Fantasy and Future of Openness

Global Genes, Local Concerns
Posted: 10 Jun 2019
Kathleen Liddell, Johnathon Liddicoat and Matthew Jordan
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

openness, open innovation, open science, genomics, synthetic biology

17.

Amicus Curiae Submission in NAFTA Proceedings Eli Lilly v. Canada

University of Cambridge Faculty of Law Research Paper No. 13/2016
Posted: 02 Mar 2016
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

intellectual property rights, patents, patent invalidation, patent revocation, utility, industrial application, new medical use inventions, selection inventions, NAFTA fair and equitable treatment, FET, state responsibility for judicial conduct, legitimate expectations, TRIPs, NAFTA